SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Pub Date : 2017-02-01 DOI:10.1002/phar.1881

K. R. Burke, Christine Schumacher, Spencer E. Harpe

引用次数: 153

Abstract

Currently only minimal information is available regarding risk factors for the development of sodium glucose cotransporter‐2 inhibitor (SGLT2i)‐related diabetic ketoacidosis (DKA). We aim to identify individual patient characteristics associated with cases of SGLT2i‐related DKA to better describe potential risk factors.

查看原文本刊更多论文

SGLT2抑制剂:主要文献中糖尿病酮症酸中毒及相关危险因素的系统综述

目前，关于葡萄糖共转运蛋白2抑制剂钠(SGLT2i)相关糖尿病酮症酸中毒(DKA)发生的危险因素的信息很少。我们的目标是确定与SGLT2i相关的DKA病例相关的个体患者特征，以更好地描述潜在的危险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

自引率

0.00%

发文量